113 related articles for article (PubMed ID: 14600449)
1. Temporal peritumoral enhancement of hepatic cavernous hemangioma: findings at multiphase dynamic magnetic resonance imaging.
Li CS; Chen RC; Chen WT; Lii JM; Tu HY
J Comput Assist Tomogr; 2003; 27(6):854-9. PubMed ID: 14600449
[TBL] [Abstract][Full Text] [Related]
2. Hepatic cavernous hemangioma: temporal peritumoral enhancement during multiphase dynamic MR imaging.
Jeong MG; Yu JS; Kim KW
Radiology; 2000 Sep; 216(3):692-7. PubMed ID: 10966696
[TBL] [Abstract][Full Text] [Related]
3. Transient peritumoral enhancement during dynamic MRI of the liver: cavernous hemangioma versus hepatocellular carcinoma.
Yu JS; Kim KW; Park MS; Yoon SW
J Comput Assist Tomogr; 2002; 26(3):411-7. PubMed ID: 12016371
[TBL] [Abstract][Full Text] [Related]
4. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
[TBL] [Abstract][Full Text] [Related]
5. Hepatic cavernous hemangioma: sonographic patterns and speed of contrast enhancement on multiphase dynamic MR imaging.
Yu JS; Kim MJ; Kim KW; Chang JC; Jo BJ; Kim TH; Lee JT; Yoo HS
AJR Am J Roentgenol; 1998 Oct; 171(4):1021-5. PubMed ID: 9762989
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of Hepatic Sclerosed Hemangiomas From Cavernous Hemangiomas Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features.
Hwang JA; Kang TW; Cha DI; Kim SH; Ha SY; Kim SW
J Comput Assist Tomogr; 2019; 43(5):762-769. PubMed ID: 31356526
[TBL] [Abstract][Full Text] [Related]
7. Perilesional enhancement of liver cavernous hemangiomas in magnetic resonance imaging.
Sousa MS; Ramalho M; Herédia V; Matos AP; Palas J; Jeon YH; Afonso D; Semelka RC
Abdom Imaging; 2014 Aug; 39(4):722-30. PubMed ID: 24531350
[TBL] [Abstract][Full Text] [Related]
8. Hepatic cavernous hemangiomas: long-term (> 5 years) follow-up changes on contrast-enhanced dynamic computed tomography or magnetic resonance imaging and determinant factors of the size change.
Choi J; Yu JS; Cho ES; Kim JH; Chung JJ
Radiol Med; 2018 May; 123(5):323-330. PubMed ID: 29357040
[TBL] [Abstract][Full Text] [Related]
9. Peritumoral fat-spared area is well correlated with the presence of temporal peritumoral enhancement in hepatic hemangioma in fatty liver.
Chen RC; Li CS; Lii JM; Chen WT; Tu HY
J Magn Reson Imaging; 2005 Jul; 22(1):86-91. PubMed ID: 15971182
[TBL] [Abstract][Full Text] [Related]
10. Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.
Soyer P; Dufresne AC; Somveille E; Scherrer A
AJR Am J Roentgenol; 1997 Feb; 168(2):461-5. PubMed ID: 9016227
[TBL] [Abstract][Full Text] [Related]
11. Ferucarbotran-enhanced T2-weighted magnetic resonance imaging: differentiation of hepatic cavernous hemangiomas from malignant solid lesions.
Cho ES; Yu JS; Ahn JH; Park MS; Kim JH; Chung JJ; Kim KW
Abdom Imaging; 2009 Jul; 34(4):494-501. PubMed ID: 18546032
[TBL] [Abstract][Full Text] [Related]
12. Atypically enhancing hepatic cavernous hemangiomas: high-spatial-resolution gadolinium-enhanced triphasic dynamic gradient-recalled-echo imaging findings.
Kato H; Kanematsu M; Matsuo M; Kondo H; Hoshi H
Eur Radiol; 2001; 11(12):2510-5. PubMed ID: 11734950
[TBL] [Abstract][Full Text] [Related]
13. Hepatic cavernous hemangiomas: relationship between speed of intratumoral enhancement during dynamic MRI and apparent diffusion coefficient on diffusion-weighted imaging.
Nam SJ; Park KY; Yu JS; Chung JJ; Kim JH; Kim KW
Korean J Radiol; 2012; 13(6):728-35. PubMed ID: 23118571
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography and magnetic resonance imaging findings of nasal cavity hemangiomas according to histological type.
Kim JH; Park SW; Kim SC; Lim MK; Jang TY; Kim YJ; Kang YH; Lee HY
Korean J Radiol; 2015; 16(3):566-74. PubMed ID: 25995686
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging: comparison with T2-weighted fast spin-echo MR imaging.
Soyer P; Corno L; Boudiaf M; Aout M; Sirol M; Placé V; Duchat F; Guerrache Y; Fargeaudou Y; Vicaut E; Pocard M; Hamzi L
Eur J Radiol; 2011 Nov; 80(2):316-24. PubMed ID: 20800983
[TBL] [Abstract][Full Text] [Related]
16. Atypically enhanced cavernous hemangiomas of the liver: centrifugal enhancement does not preclude the diagnosis of hepatic hemangioma.
Matsushita M; Takehara Y; Nasu H; Hirai Y; Yamashita S; Souda K; Kobayashi Y; Miura K
J Gastroenterol; 2006 Dec; 41(12):1227-30. PubMed ID: 17287903
[TBL] [Abstract][Full Text] [Related]
17. Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings.
Mastropasqua M; Kanematsu M; Leonardou P; Braga L; Woosley JT; Semelka RC
Magn Reson Imaging; 2004 Jan; 22(1):15-8. PubMed ID: 14972389
[TBL] [Abstract][Full Text] [Related]
18. Hepatic cavernous hemangioma in cirrhotic liver: imaging findings.
Yu JS; Kim KW; Park MS; Yoon SW
Korean J Radiol; 2000; 1(4):185-90. PubMed ID: 11752953
[TBL] [Abstract][Full Text] [Related]
19. Hepatic cavernous hemangiomas: patterns of contrast enhancement on MR fluoroscopy imaging.
Unal O; Sakarya ME; Arslan H; Tuncer I; Etlik O
Clin Imaging; 2002; 26(1):39-42. PubMed ID: 11814752
[TBL] [Abstract][Full Text] [Related]
20. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.
Byun JH; Kim TK; Lee CW; Lee JK; Kim AY; Kim PN; Ha HK; Lee MG
Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
